Five healthy, unmedicated male volunteers, aged 19-25 yr, participated in a double-blind, crossover study. Each subject received, on separate occasions and via a catheter placed at L2, 1.5% etidocaine HC120 ml with adrenaline 5 ng/ml, or 0.75% bupivacaine HC1 20 ml with adrenaline 5 ng/ml for extradural analgesia. In addition, in order to calculate the absorption rate of the local anaesthetic agent, each subject received on two further occasions etidocaine HC175 mg and bupivacaine HC175 mg respectively by i.v. infusion, over a period of 10 min. Spread of sensory analgesia to four segments above and below the site of injection was faster with etidocaine (13 ± 3 min) (mean ± SD) than with bupivacaine (22 + 8 min). Two-segment regression occurred later for bupivacaine (260 ±57 min) than for etidocaine (180 ±96 min). Caudal spread of analgesia was more extensive with etidocaine than with bupivacaine. The onset of motor blockade tended to be faster with etidocaine (5.8 ±3.0 min), than with bupivacaine (10.0 + 3.5 min); regression of motor blockade by one unit was longer with etidocaine (306 ±103 min) than bupivacaine (238 ± 75 min). Sudomotor block occurred earlier with etidocaine (4.0 ±2.1 min) than bupivacaine (13.7 ±4.8 min). Significant changes in cardiac stroke work and stroke volume occurred. In an earlier report we described the cardiovascular effects, block characteristics and blood concentrations of a new long-acting local anaesthetic agent, etidocaine HC1 (Duranest), in an investigation in which it was compared with lignocaine HC1 (Xylocaine) for extradural block. Lignocaine HC1 was chosen because it has become a standard reference against which other, agents are compared. However, lignocaine has a short duration of action and we felt that it would be appropriate to compare
etidocaine with an established long-acting agent, bupivacaine (Marcaine). This report describes a double-blind, crossover study in which both bupivacaine and etidocaine were administered by: (a) the extradural route and (b) i.v. infusion to the same individual on different occasions.
METHODS
Five healthy, unmedicated male volunteers, aged 19-25 yr, gave informed consent for this study (table  I) . Because of the double-blind, crossover nature of this investigation, it was necessary to perform each study in a random order such that an interval of at least 3 weeks elapsed between studies in the same individual. On each of two occasions the subject received an extradural block with 20 ml of either etidocaine 1.5% or bupivacaine 0.75% respectively (all solutions contained adrenaline 1 : 200 000 5 /xg/ml). In two further studies each subject received etidocaine and bupivacaine in a dose of 75 mg by i.v. infusion. The systemic disposition constant of each individual obtained from the separate i.v. studies are employed to derive a relationship between the fraction of the dose absorbed and time (Loo and Riegelman, 1968; Tucker and Mather, 1975) . Further details of these studies will be reported separately.
Catheterization of the brachial artery and basilic vein were performed under local anaesthesia and measurements of mean arterial pressure (MAP), central venous pressure (CVP) and cardiac output (CO) were made. The total peripheral resistance (TPR) and stroke volume (SV) were calculated and arm and leg blood flows (ABF and LBF) were measured by venous occlusive plethysmography. Stroke work (SW) was calculated from SV and MAP, and minute work (MW) was calculated from CO and MAP. The techniques and methods of measurements have been described previously (Bonica et al., , 1972 Bonica, Berges and Morikawa, 1970) . For extradural block, a Teflon catheter was placed so that its tip lay at the level of the L2 intervertebral space.
Following the insertion of catheters and application of other equiment, the subject was allowed a rest period of at least half an hour and this was followed by control measurements of all the variables. After the injection of the local anaesthetic solution, the segmental levels of both hypoaesthesia and analgesia were determined by pinprick and plotted as a function of time. Motor function was recorded on a scale of 0-4, where 0 reflects the subject's ability for straight leg flexion at the hip (L2-3), 1 describes hip flexion with sufficient quadriceps paresis to prevent extension at the knee (L3-4) 2 indicates inability to raise the leg while maintaining dorsiflexion of the foot (L4-5), 3 describes evidence of eversion of the foot (SI) and 4 indicates total paralysis (modified from Bromage et al. (1964) ).
Sympathetic function was assessed by observation of sudomotor and vasomotor activities. The former was measured by the abolition and reappearance of the psychogalvanic reflex (PGR) using electrodes placed on the dorsal and plantar aspects of the same foot. Vasomotor activity was determined by the temperature change of the great toe measured by a skin temperature probe. Cardiovascular and respiratory changes were measured until all somatic and motor block had regressed. Serial blood samples were taken from catheters placed in a brachial artery and cephalic vein and the plasma local anaesthetic concentrations were measured by gas chromatography .
The cardiovascular data were analysed using Student's t test for paired data while the Wilcoxon non-parametric test for paired data (Sokal and Rohlf, 1969) was used for analysis of the nerve blocking characteristics.
RESULTS
A striking similarity was apparent between each pair of time-segment profiles obtained with both agents. In all but one volunteer there was a significant delay in the onset of anaesthesia in segments L5-S1 and there was a failure to achieve total analgesia in dermatome SI in six out of 10 individuals. However, hypoaesthesia, as defined by an altered sensation to pinprick, was observed in those segments which were not rendered totally analgesic. Etidocaine appeared to possess a greater capacity to block roots L5-S1 than did bupivacaine. This trend was supported by nonparametric statistical analysis of the data, which showed that a significantly greater number of caudal segments were blocked by etidocaine (table II, fig. 1 ). This study confirmed our earlier view (StantonHicks et al., 1975) that "operative onset" is a useful criterion when applied to the problem of predicting, at an early stage, the number of dermatomes that will be blocked and the duration of analgesia. Operative onset may be defined as the time taken to achieve analgesia in four segments above and below the injection site. Bupivacaine was significantly slower in producing analgesia in these eight dermatomes (22±8min) than was etidocaine (13 + 3 min) (mean ± SD). Two-segment regression was significantly longer for bupivacaine (260 + 57 min) than for etidocaine (180 ±96 min). Although the duration of analgesia was significantly longer for etidocaine, the late segmental distribution was too limited to be useful clinically (table II) .
The onset of motor block was significantly faster for etidocaine (5.8 + 3.0 min) compared with bupivacaine (10.0 ±3.5 min), and both regression by one unit (306 ±103 min) and duration (516 ±234 min) were significantly longer for etidocaine than with bupivacaine (238 ±75 min and 472±159min
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PSYCHOGALVANIC REFLEX fig. 2) ). Loss of PGR occurred earlier with etidocaine (4.0 + 2.1 min) than with bupivacaine (13.7 ±4.8 min). A previous conclusion (StantonHicks et al., 1975 ) that regression in the uppermost two or three dermatomes bore a close relationship to the return of PGR was supported by the data (Murphy et al., 1975) . However, in two out of 10 studies a greater number of dermatomes (four and MEAN ARTERIAL PRESSURE five in subjects C and E, respectively (figs 1 and 2) had regained sensation before PGR returned. Significant differences in vasomotor activity between the two local anaesthetic agents were noted. With bupivacaine the maximum increase in temperature occurred later, the increase was maintained for a longer period and the decline in temperature was slower (table II) . 
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Cardiovascular effects
The cardiovascular changes induced by these drugs did not differ significantly. They were characteristic of the effects of absorbed adrenaline and vasomotor block (Bromage, 1967; Lofstrom et al., 1970; Bonica et al., 1972; Stanton-Hicks, Berges and Bonica, 1973) .
With etidocaine, SW and MW were depressed for 2-3| h but reverted gradually to control values by 5 h after injection. With etidocaine MAP was depressed concurrently with the depression of SW and MW. The principal cardiovascular responses are summarized in table III and figures 3 and 4.
Pharmacokinetics
The arterial plasma concentrations of etidocaine ( fig. 5 ) increased rapidly after injection and reached a maximum at 14 ±2 min. With bupivacaine a. maximum was reached at 20 + 4 min. The concentrations of both drugs decreased rapidly and were approximately 50% of the peak values by 1 h, and 30% of the peak values by 4 h. For venous blood the maximum drug concentrations were approximately 60% of the corresponding arterial concentra- tions at approximately corresponding times. Two hours and subsequently following injection arterial and venous concentrations were approximately equal. For each subject, the unabsorbed fraction of the dose was plotted against time ( fig. 6 ). There was no consistency in the relative absorption curves. Etidocaine was absorbed more slowly in two of the five subjects, and the absorption of bupivacaine was slower in the other three subjects (table IV) .
DISCUSSION
Both local anaesthetic agents achieved maximal spread of analgesia within approximately the same time. This is consistent with a number of recent reports (Moore et al., 1970 Engberg, Holmdahl and Edstrom, 1974) . However, the time taken for four segments above and below the injection site to be blocked, "operative onset" , was significantly shorter with etidocaine than with bupivacaine. This modality may be important clinically because it helps the anaesthetist to predict, at an early stage, the adequacy of segmental analgesia for the proposed surgical procedure. It was evident also that etidocaine exhibited a greater degree of caudal spread than bupivacaine. The reasons for this are not evident. Both agents are very soluble in fat, although etidocaine is more soluble than bupivacaine, and we would have expected similar uptake characteristics. Although lignocaine is much less soluble in fat than either etidocaine or bupivacaine, lignocaine with adrenaline has a greater average sacral spread than etidocaine with adrenaline . Subjects C and E developed the least sacral analgesia with bupivacaine, and the data indicate that they had the greatest proportion of unabsorbed bupivacaine remaining in the extradural space. There are two possible interpretations. First, that non-specific binding of local anaesthetic agents is important in reducing the amount of drug available for penetration of the nerve roots, accounting for the efficiency of any given dose of local anaesthetic agent. Second, the bulk of the drug may remain in the thoraco-lumbar region, and only a relatively ineffective concentration is present in the sacral region. U = per cent dose unabsorbed. ^ and ijj are respectively fast and slow absorption constants and t/2 % and t/2 tji are respectively fast and slow absorption half-lives. X and Y are fractions of dose proceeding via the respectively fast and slow pathways.
The phenomenon of missed segmental analgesia in dermatomes L5-S1 has been the subject of a number of reports (Bromage, 1962; Bromage et al., 1967; Galindo et al., 1975; Gitschmann and Nolte, 1975) . Galindo and colleagues (1975) have related the failure to anaesthetize L5 and SI to the diameter of these nerves. Embryologically, the first sacral segment is important for the outgrowth of the nervous system into the developing lower limb bud and it becomes the largest formed spinal nerve in the body (Last, 1972) . Galindo and colleagues (1975) showed also that youth affected adversely the success with which a local anaesthetic agent would achieve analgesia in these nerve roots. The present study confirms these findings, although our data with etidocaine 1.5% do not agree with those of Galindo and colleagues (1975) who achieved analgesia in all instances with this concentration although their subjects were premedicated patients.
We have found that etidocaine has a shorter latency than bupivacaine for the onset of motor block. These results are in agreement with those of other authors (Lund, Cwik and Pagdanganan, 1973; Lund, Cwik and Gannon, 1975; Niesel and Munch, 1975) . Both agents developed their maximum motor block within a comparable time, but the block obtained with etidocaine was of significantly longer duration. Subjects B, D and E voiced their subjective impression that the motor block was more intense on the occasion of their study with etidocaine. In all studies, BRITISH JOURNAL OF ANAESTHESIA muscle power was regained fully before the complete return of normal sensation.
Although of little clinical importance, the significant reductions in SW and MW which occurred with etidocaine at 120 and 210 min after injections deserve discussion.
Several studies have shown that the cardiac effects of adrenaline last 90-120 min when a dose of 100 y.g is introduced into the extradural space Bonica et al., 1972; . One may postulate that etidocaine or its metabolites or both, exerted a mild depressant effect on the myocardium but that this effect was antagonized by beta-stimulation of the heart as a result of the high catecholamine concentrations. Therefore, when the catecholamine concentrations decreased below a critical value, the negative inotropic effects of the local anaesthetic were manifested by a small reduction in cardiac performance. However, during i.v. administration of etidocaine in a dose which would produce plasma concentrations 20-50% of those found in the present study, negative inotropic effects were not seen and therefore our interpretation may be invalid. The changes in stroke work, minute work and cardiac output between 120 and 210 min may be more apparent than real. An analysis of variance of these data suggests that the diverging curves of stroke work and minute work between 120 and 210 min ( fig. 3) , may be accounted for by biological variation. In several studies etidocaine has been shown to reduce the tone of both capacitance and resistance vessels of in vitro and in vivo preparations (Blair, 1975) . Interestingly, the central venous pressure did not reflect any venomotor changes which could be attributed to either drug.
The plasma concentrations of both drugs were similar despite the difference in the dose injected. This reflects the greater mean total body clearance and greater volume of distribution of etidocaine rather than absorption rate differences and other differences proposed by Lund, Cwik and Pagdanganan (1973) and Lund, Cwik and Gannon (1975) . The fitted absorption curves follow a bi-exponential relationship and our data indicate that the average fast and slow half-lives are approximately 20 min and 8 h for both drugs respectively. Extrapolation of the absorption-time relationship by digital computer indicates that by 25 h after injection, the absorption of both drugs from the site of injection would exceed 90%, and that the rate of absorption would be slightly more rapid for bupivacaine.
